Cited by 194Muscle Physiology and DisordersNeurogenetic and Muscular Disorders ResearchVirus-based gene therapy research

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

Open access

Rodino‐Klapac, Louise R., Haidet, Amanda M., Kota, Janaiah, Handy, Chalonda, Kaspar, Brian K., Mendell, Jerry R.·2009·Muscle & Nerve

DOI 10.1002/mus.21244PMC PMC2717722

Open this paper in CoChat — free account

Abstract

In most cases, pharmacologic strategies to treat genetic muscle disorders and certain acquired disorders, such as sporadic inclusion body myositis, have produced modest clinical benefits. In these conditions, inhibition of the myostatin pathway represents an alternative strategy to improve functional outcomes. Preclinical data that support this approach clearly demonstrate the potential for blocking the myostatin pathway. Follistatin has emerged as a powerful antagonist of myostatin that can increase muscle mass and strength. Follistatin was first isolated from the ovary and is known to suppress follicle-stimulating hormone. This raises concerns for potential adverse effects on the hypothalamic-pituitary-gonadal axis and possible reproductive capabilities. In this review we demonstrate a strategy to bypass off-target effects using an alternatively spliced cDNA of follistatin (FS344) delivered by adeno-associated virus (AAV) to muscle. The transgene product is a peptide of 315 amino acids that is secreted from the muscle and circulates in the serum, thus avoiding cell-surface binding sites. Using this approach our translational studies show increased muscle size and strength in species ranging from mice to monkeys. Adverse effects are avoided, and no organ system pathology or change in reproductive capabilities has been seen. These findings provide the impetus to move toward gene therapy clinical trials with delivery of AAV-FS344 to increase size and function of muscle in patients with neuromuscular disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/mus.21244

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Transcriptional control by the TGF‐β/Smad signaling system
Massagué, J., & Wotton, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,990
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004356200 · Cited by 1,014
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B. C., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 910
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883
Functional improvement of dystrophic muscle by myostatin blockade
Bogdanovich, S., Krag, T. O. B., Barton, E. R., Morris, L. D., Whittemore, L.-A., Ahima, R. S., & Khurana, T. S. (2002) · Nature · doi:10.1038/nature01154 · Cited by 831
REGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
Sampaolesi, M., Blot, S., D’Antona, G., Granger, N. P., Tonlorenzi, R., Innocenzi, A., Mognol, P., Thibaud, J. L., Gálvez, B. G., Barthélémy, I., et al. (2006) · Nature · doi:10.1038/nature05282 · Cited by 768
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Gregorevic, P., Blankinship, M. J., Allen, J. M., Crawford, R. W., Meuse, L., Miller, D. G., Russell, D. W., & Chamberlain, J. S. (2004) · Nature Medicine · doi:10.1038/nm1085 · Cited by 620
Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use
Pope, H. G. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050035004 · Cited by 606
Multiple defects and perinatal death in mice deficient in follistatin
Matzuk, M. M., Lu, N., Vogel, H. S., Sellheyer, K., Roop, D. R., & Bradley, A. (1995) · Nature · doi:10.1038/374360a0 · Cited by 584
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E., & Sweeney, H. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7866 · Cited by 579
Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis
Rebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., & Attisano, L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7230-7242.2003 · Cited by 573
Emerging Themes in Lipid Rafts and Caveolae
Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00472-x · Cited by 567
Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular Dystrophy
Mendell, J. R., Moxley, R. T., Griggs, R. C., Brooke, M. H., Fenichel, G. M., Miller, J. P., King, W. M., Signore, L., Pandya, S., Florence, J. M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202405 · Cited by 520
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
Lee, S.-J., Reed, L. A., Davies, M. V., Girgenrath, S., Goad, M. E. P., Tomkinson, K. N., Wright, J. F., Barker, C., Ehrmantraut, G., Holmstrom, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505996102 · Cited by 501
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
Wagner, K. R., Fleckenstein, J. L., Amato, A. A., Barohn, R. J., Bushby, K., Escolar, D. M., Flanigan, K. M., Pestronk, A., Tawil, R., Wolfe, G. I., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21338 · Cited by 481
Self-citation
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.
Ueno, N., LING, N. C., Ying, S. Y., Esch, F. S., Shimasaki, S., & Guillemin, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8282 · Cited by 445
The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum
Hill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 444
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
Wagner, K. R., McPherron, A. C., Winik, N., & Lee, S. (2002) · Annals of Neurology · doi:10.1002/ana.10385 · Cited by 378
Use of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 349
The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin
Robertson, D. M., Klein, R., de Vos, F. L., McLachlan, R. I., Wettenhall, R. E. H., Hearn, M. T. W., Burger, H., & de Kretser, D. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90430-x · Cited by 345
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
Minetti, G., Colussi, C., Adami, R., Serra, C., Mozzetta, C., Parente, V., Fortuni, S., Straino, S., Sampaolesi, M., Padova, M. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1479 · Cited by 343
Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz‐Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha‐Hikim, I., Hogue, A., Fielder, T. J., & González-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
Immune Responses to AAV in Clinical Trials
Mingozzi, F., & A. High, K. (2011) · Current Gene Therapy · doi:10.2174/156652311796150354 · Cited by 324
Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways
Lee, S.-J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000789 · Cited by 316
Clinical gene therapy using recombinant adeno-associated virus vectors
Mueller, C., & Flotte, T. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.68 · Cited by 312
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Gregorevic, P., Allen, J. M., Minami, E., Blankinship, M. J., Haraguchi, M., Meuse, L., Finn, E. E., Adams, M. E., Froehner, S. C., Murry, C. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1439 · Cited by 309
Practice Parameter: Corticosteroid treatment of Duchenne dystrophy [RETIRED]
Moxley, R. T., Ashwal, S., Pandya, S., Connolly, A. M., Florence, J. M., Mathews, K. D., Baumbach, L. L., McDonald, C. M., Sussman, M. D., & Wade, C. (2005) · Neurology · doi:10.1212/01.wnl.0000148485.00049.b7 · Cited by 301
Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia
Jones, K. L., Mansell, A. S., Patella, S., Scott, B. J., Hedger, M. P., de Kretser, D., & Phillips, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705971104 · Cited by 284
Follistatin: A Multifunctional Regulatory Protein
Phillips, D. J., & de Kretser, D. M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0169 · Cited by 274
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Haidet, A. M., Rizo, L., Handy, C. R., Umapathi, P., Eagle, A., Shilling, C., Boué, D. R., Martin, P. T., Sahenk, Z., Mendell, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709144105 · Cited by 274
Myostatin Directly Regulates Skeletal Muscle Fibrosis
Li, Z. B., Kollias, H. D., & Wagner, K. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802585200 · Cited by 267
Comparative Genome Map of Human and Cattle
Solinas‐Toldo, S., Lengauer, C., & Fries, R. (1995) · Genomics · doi:10.1006/geno.1995.1081 · Cited by 266
Myostatin propeptide‐mediated amelioration of dystrophic pathophysiology
Bogdanovich, S., Perkins, K. J., Krag, T. O. B., Whittemore, L.-A., & Khurana, T. S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2796com · Cited by 244
Immune Responses to AAV in Clinical Trials
Mingozzi, F., & High, K. A. (2007) · Current Gene Therapy · doi:10.2174/156652307782151425 · Cited by 241
Primary structure of the human follistatin precursor and its genomic organization
Shimasaki, S., Koga, M., Esch, F., Cooksey, K., Mercado, M., Koba, A., Ueno, N., Ying, S. Y., Ling, N., & Guillemin, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4218 · Cited by 232
Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell
Sugino, K., Kurosawa, N., Nakamura, T., Takio, K., Shimasaki, S., LING, N. C., Titani, K., & Sugino, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82296-7 · Cited by 228
Regulation of Myostatin in Vivo by Growth and Differentiation Factor-Associated Serum Protein-1: A Novel Protein with Protease Inhibitor and Follistatin Domains
Hill, J. J., Qiu, Y., Hewick, R. M., & Wolfman, N. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0366 · Cited by 225
Overexpression of Mouse Follistatin Causes Reproductive Defects in Transgenic Mice
Guo, Q., Kumar, T. R., Woodruff, T. K., Hadsell, L. A., DeMayo, F. J., & Matzuk, M. M. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0053 · Cited by 209
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
McClorey, G., Moulton, H. M., Iversen, P. L., Fletcher, S., & Wilton, S. D. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302800 · Cited by 208
Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-β Family
Tsuchida, K., Arai, K. Y., Kuramoto, Y., Yamakawa, N., Hasegawa, Y., & Sugino, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006114200 · Cited by 192
A Novel Role of Follistatin, an Activin-binding Protein, in the Inhibition of Activin Action in Rat Pituitary Cells
Hashimoto, O., Nakamura, T., Shoji, H., Shimasaki, S., Hayashi, Y., & Sugino, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13835 · Cited by 186
Adeno-Associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury
Liu, M., Yue, Y., Harper, S. Q., Grange, R. W., Chamberlain, J. S., & Duan, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.013 · Cited by 178
Structural Characterization of Follistatin: A Novel Follicle-Stimulating Hormone Release-Inhibiting Polypeptide from the Gonad
Esch, F. S., Shimasaki, S., Mercado, M., Cooksey, K., LING, N. C., Ying, S., Ueno, N., & Guillemin, R. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-11-849 · Cited by 175
Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice
Qiao, C., Li, J., Jiang, J., Zhu, X., Wang, B., Li, J., & Xiao, X. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.159 · Cited by 161
Caveolae — from ultrastructure to molecular mechanisms
Parton, R. G. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1017 · Cited by 151
The Regulation and Action of Myostatin as a Negative Regulator of Muscle Development during Avian Embryogenesis
Amthor, H., Huang, R., McKinnell, I. W., Christ, B., Kambadur, R., Sharma, M., & Patel, K. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0812 · Cited by 138
Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders
Lenders, J. W. M., Demacker, P. N. M., Vos, J., Jansen, P. L. M., Hoitsma, A. J., Laar, A. V. '., & Thien, T. A. (1988) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024972 · Cited by 126
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer
Cerletti, M., Negri, T., Cozzi, F., Colpo, R., Andreetta, F., Croci, D., Davies, K. E., Cornelio, F., Pozza, O., Karpati, G., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301941 · Cited by 126
Muscular atrophy of caveolin-3–deficient mice is rescued by myostatin inhibition
Ohsawa, Y., Hagiwara, H., Nakatani, M., Yasue, A., Moriyama, K., Murakami, T., Tsuchida, K., Noji, S., & Sunada, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28520 · Cited by 122
Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing
Shimasaki, S., Koga, M., Esch, F. S., Mercado, M., Cooksey, K., Koba, A., & LING, N. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80097-4 · Cited by 115
The androgen receptor A mediator of diverse responses
Chang, C. (1996) · Frontiers in bioscience · doi:10.2741/a116 · Cited by 104
Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular Dystrophy
Parsons, S. A., Millay, D. P., Sargent, M. A., McNally, E. M., & Molkentin, J. D. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051316 · Cited by 102
Therapeutic potential of follistatin for colonic inflammation in mice
Dohi, T., Ejima, C., Kato, R., Kawamura, Y. I., Kawashima, R., Mizutani, N., Tabuchi, Y., & Kojima, I. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.063 · Cited by 95
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency
Bartoli, M., Poupiot, J., Vulin, A., Fougerousse, F., Arandel, L., Danièle, N., Roudaut, C., Noulet, F., Garcı́a, L., Danos, O., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302928 · Cited by 85
A CAV3 microdeletion differentially affects skeletal muscle and myocardium
Cagliani, R., Bresolin, N., Prelle, A. C., Gallanti, A., Fortunato, F., Sironi, M., Ciscato, P., Fagiolari, G., Bonato, S., Galbiati, S., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000097320.35982.03 · Cited by 84
Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons
Aartsma-Rus, A. M., Kaman, W. E., Weij, R., den Dunnen, J. T., van Ommen, G. B., & van Deutekom, J. C. T. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.022 · Cited by 79
Myostatin blockade improves function but not histopathology in a murine model of limb‐girdle muscular dystrophy 2C
Bogdanovich, S., McNally, E. M., & Khurana, T. S. (2007) · Muscle & Nerve · doi:10.1002/mus.20920 · Cited by 77
Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin
Evans, L., Muttukrishna, S., & Groome, N. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560275 · Cited by 77
Transcriptional activation of the gonadotropin-releasing hormone receptor gene by activin A
Fernández‐Vázquez, G., Kaiser, U. B., Albarracin, C. T., & Chin, W. W. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.4.8721981 · Cited by 75
Phenotypic Improvement of Dystrophic Muscles by rAAV/Microdystrophin Vectors Is Augmented by Igf1 Codelivery
Abmayr, S., Gregorevic, P., Allen, J. M., & Chamberlain, J. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.001 · Cited by 73
Prospective Echocardiographic Assessment of Androgenic-Anabolic Steroids Effects on Cardiac Structure and Function in Strength Athletes
Hartgens, F., Cheriex, E. C., & Kuipers, H. (2003) · International Journal of Sports Medicine · doi:10.1055/s-2003-40705 · Cited by 71
Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay
Schneyer, A. L., Wang, Q., Sidis, Y., & Sluss, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0162 · Cited by 71
The Congenital Muscular Dystrophies: Recent Advances and Molecular Insights
Mendell, J. R., Boué, D. R., & Martin, P. T. (2006) · Pediatric and Developmental Pathology · doi:10.2350/06-07-0127.1 · Cited by 69
Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency.
Kuang, W., Xu, H. M., Vilquin, J., & Engvall, E. (1999) · PubMed · Cited by 69
Elimination of Myostatin Does Not Combat Muscular Dystrophy in dy Mice but Increases Postnatal Lethality
Li, Z., Shelton, G. D., & Engvall, E. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62271-7 · Cited by 67
Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin
Khoury, R. H., Wang, Q. F., Crowley, W. F., Hall, J. E., Schneyer, A. L., Toth, T. L., MIDGLEY, A. R., & Sluss, P. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.4.7714112 · Cited by 63
Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women
WAKATSUKI, M., Shintani, Y., Abe, M., Liu, Z. H., Shitsukawa, K., & Saito, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636280 · Cited by 52
Activin A and follistatin are dynamically regulated during human pregnancy
Woodruff, T. K., Sluss, P., Wang, E., Janssen, I., & Mersol-Barg, M. S. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1520167 · Cited by 50
Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.
Hamed, S. A. (2006) · PubMed · Cited by 48
The Heparin Binding Site of Follistatin Is Involved in Its Interaction with Activin
Sumitomo, S., Inouye, S., Liu, X. J., LING, N. C., & Shimasaki, S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1297 · Cited by 43
Administration of myostatin does not alter fat mass in adult mice
Stolz, L. E., Li, D., Qadri, A., Jalenak, M., Klaman, L. D., & Tobin, J. F. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00672.x · Cited by 40
Transcriptional activation of the gonadotropin-releasing hormone receptor gene by activin A
Fernandez-Vazquez, G. (1996) · Molecular Endocrinology · doi:10.1210/me.10.4.356 · Cited by 39
Oxandrolone enhances skeletal muscle myosin synthesis and alters global gene expression profile in Duchenne muscular dystrophy
Balagopal, P., Olney, R. C., Darmaun, D., Mougey, E. B., Dokler, M., Sieck, G. C., & Hammond, D. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00412.2005 · Cited by 38
Reduced High-Density Lipoprotein-Cholesterol in Power Athletes: Use of Male Sex Hormone Derivates, an Atherogenic Factor
Alén, M., & Rahkila, P. (1984) · International Journal of Sports Medicine · doi:10.1055/s-2008-1025929 · Cited by 36
A CAV3 microdeletion differentially affects skeletal muscle and myocardium
Finsterer, J., & Stoellberger, C. (2004) · Neurology · doi:10.1212/wnl.63.1.195 · Cited by 33
Development and validation of a radioimmunoassay for follistatin in human serum
Gilfillan, C. P., & Robertson, D. M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02576.x · Cited by 27
Chronic Inhibitory Effect of Follicle-Stimulating Hormone (FSH)-Suppressing Protein (FSP) or Follistatin on Activin- and Gonadotropin-Releasing Hormone-Stimulated FSH Synthesis and Secretion in Cultured Rat Anterior Pituitary Cells*
WANG, Q. F., Farnworth, P. G., Findlay, J. K., & Burger, H. (1990) · Endocrinology · doi:10.1210/endo-127-3-1385 · Cited by 24
Acute inhibitory effect of follicle-stimulating hormone-suppressing protein (FSP) on gonadotropin-releasing hormone-stimulated gonadotropin secretion in cultured rat anterior pituitary cells
Wang, Q. F., Farnworth, P. G., Burger, H., & Findlay, J. K. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90237-3 · Cited by 12
Left Ventricular Dimensions and Function in Strength Athletes
Kindermann, W., & Urhausen, A. J. P. (2004) · International Journal of Sports Medicine · doi:10.1055/s-2004-817850 · Cited by 7

Flagged first, then by citations

Research works printed but not linked: 2

10.1210/jc.80.4.1361 · DOI
10.1210/jc.81.2.630 · DOI

Sorted by citations

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Aberrant repair and fibrosis development in skeletal muscle
Mann, C. J., Perdiguero, E., Kharraz, Y., Aguilar, S., Pessina, P., Serrano, A. L., & Muñoz-Cánoves, P. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-21 · Cited by 853
“Normal myostatin signaling can be counter-regulated by the extracellular protein follistatin [95].”
Background
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018424 · Cited by 534
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 320
Regulation of Muscle Mass by Follistatin and Activins
Lee, S.-J., Lee, Y.-S., Zimmers, T. A., Soleimani, A., Matzuk, M. M., Tsuchida, K., Cohn, R. D., & Barton, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0127 · Cited by 273

See all 194

Authors: Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R.
Affiliations: Nationwide Children's Hospital (US)
Corresponding author: Mendell, Jerry R.
ORCID: Rodino‐Klapac, Louise R.
Kota, Janaiah
Kaspar, Brian K.
Mendell, Jerry R.
Venue: Muscle & Nerve
Publisher: Wiley
Published: 2009-02-10
Volume: 39
Issue: 3
Pages: 283-296
ISSN: 0148-639X (ISSN-L)
1097-4598
DOI: 10.1002/mus.21244
PMC: PMC2717722
OpenAlex: W2108645449
Cited by: 194
References: 83
Citations by year: 2026: 6 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 13 · 2019: 12 · 2018: 14 · 2017: 7 · 2016: 14 · 2015: 10 · 2014: 10 · 2013: 10 · 2012: 21
FWCI: 1.63
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Muscle & Nerve (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (F31NS058224)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords: myostatin inhibition, follistatin, adeno-associated virus gene therapy, myopathy, neuromuscular disorders, sporadic inclusion body myositis, muscle mass and strength, hypothalamic-pituitary-gonadal axis, reproductive safety, alternative splicing
MeSH terms: Dependovirus, Animals, Humans, Mice, Mutant Strains, Muscles, Muscular Diseases, Genetic Therapy, Alternative Splicing, DNA, Complementary, Follistatin, Mice, Myostatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks